T2 Biosystems Inc (NASDAQ:TTOO) has been assigned an average recommendation of “Buy” from the eight ratings firms that are presently covering the firm, Marketbeat.com reports. One research analyst has rated the stock with a sell rating, two have given a hold rating and five have issued a buy rating on the company. The average twelve-month target price among brokers that have issued a report on the stock in the last year is $8.40.
Several equities research analysts recently commented on TTOO shares. ValuEngine raised T2 Biosystems from a “sell” rating to a....More>>>